Relmada Therapeutics Appoints Michael Becker as Senior Vice President of Finance and Corporate Development
Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Michael D. Becker as senior vice president of finance and corporate development, effective immediately.
View full press release